CoViD-19 Nucleic Acid Detection Kit
OaCP informs that the CoViD-19 Nucleic Acid Detection Kit is not a domestic use kit and that the contents of this site are intended exclusively for healthcare professionals.
CoViD-19 Detection Kit
Clinical significance: According to the “New Coronavirus Pneumonia Infection Diagnosis and Treatment Plan” (Trial Version 5) the CoViD 19 nucleic acid test is the gold standard for the diagnosis of suspected patients.
Product Characteristics
Accurate results: the kit contains an internal standard to avoid false negative results and ensure the accuracy of the test result.
Anti-pollution: the principle of “One step” PCR technology reduces reaction time and avoids aerosol pollution.
High sensitivity: the minimum detection baseline is 500 copies/mL, which ensures the detection of low virus content sample results.
High-throughput: triple PCR reaction system, high detection flux, timely and rapid completion of multiple sample detection.
CE-IVD and CFDA approved.
OaCP and its kit have been listed as certified entities in the Circular of Italy’s Ministry of Health published on 04/03/2020. The document contains updates about indications on diagnostic tests and criteria to follow in the determination of priorities within COVID-19 pandemic.
INFORMATION
For any further information or requests please contact us:
ask@oacp.it | ceo@oacp.it
Distributed by:
Distributed in Lebanon, Irak, Jordan, UAE, KSA, Kuwait, Qatar by:
